Key Financial Data Of Reporting Company

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7586092

Concept 2022-07-01 to
2022-09-30
As at
2022-09-30
2022-04-01 to
2022-09-30
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-09-30
2021-07-01 to
2021-09-30
2021-04-01 to
2021-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
30,172,000,000 JPY
56,607,000,000 JPY
28,477,000,000 JPY
Ordinary profit (loss)
2,987,000,000 JPY
4,880,000,000 JPY
2,743,000,000 JPY
Net assets
52,002,000,000 JPY
48,892,000,000 JPY
41,790,000,000 JPY
Total assets
86,227,000,000 JPY
83,297,000,000 JPY
78,295,000,000 JPY
Basic earnings (loss) per share
36.25
83.18
151.22
-137.17
-98.52
Diluted earnings per share
Equity-to-asset ratio
0.603 xbrli:pure
0.587 xbrli:pure
0.534 xbrli:pure
Net cash provided by (used in) operating activities
1,666,000,000 JPY
2,842,000,000 JPY
1,417,000,000 JPY
Net cash provided by (used in) investing activities
-199,000,000 JPY
6,743,000,000 JPY
-427,000,000 JPY
Net cash provided by (used in) financing activities
-1,346,000,000 JPY
-2,996,000,000 JPY
-1,386,000,000 JPY
Cash and cash equivalents
17,224,000,000 JPY
17,103,000,000 JPY
10,117,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.